LONGMONT, Colo.--(BUSINESS WIRE)--nSpire Health, LLC, a leading provider of respiratory diagnostic devices and clinical trial services, today announced that first half earnings before interest and taxes was up 22% when compared to the same period for 2010. “First half sales of $14.4M are up 6% year over year and our balance sheet remains strong. Our cash position is at the same level it was last year at this time despite reducing our debt by 60% or $300K and prudently investing in working capital and fixed assets,” said David Jackson, Executive Vice President and CFO.
